Northwestern Mutual Wealth Management CO Halozyme Therapeutics, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $118 Billion
- Q4 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 313 shares of HALO stock, worth $18,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
313
Previous 343
8.75%
Holding current value
$18,060
Previous $19,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding HALO
# of Institutions
548Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$766 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$415 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$241 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$199 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.04B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...